Dr. Van Schoor provides scientific expertise and guidance relating to the implementation of electronic clinical outcome assessments (eCOAs), and has a special focus on eDiary design and accessibility of eCOA best practices. She completed her PhD in Physiological Sciences at Stellenbosch University, which focused on the bacterial and inflammatory involvement in colorectal carcinogenesis, and has 3+ years’ experience in the clinical research industry. She has given scientific consultation for projects across a wide range of therapeutic areas, including  oncology, infectious disease, dermatology, and gastroenterology.

Lauren has comprehensive cross-functional experience within the life sciences and information technology sectors. At Signant, she combines this experience to provide scientific consultation and support to clients on the implementation of eCOA to optimize patient care and outcomes in clinical trials. She has supported eCOA projects across multiple therapeutic areas, including dermatology and neurology, with a current focus on respiratory diseases

Dr. Busner has more than 35 years of experience as an academic psychiatric researcher and psychopharmacology principal investigator and founded and directed two university psychiatric clinical trials units. Dr. Busner served continuously on University Institutional Review Boards for 20 years. At Signant she has scientific and clinical responsibility for studies in mood, anxiety, pediatrics, and rare/orphan diseases. Dr. Busner is currently Affiliate Associate Professor of Psychiatry at Virginia Commonwealth University.

Dr. Byrom has over 30 years’ experience as a clinical development specialist, an eClinical product strategy leader, and an industry expert in clinical outcome assessments.  He has authored 80+ publications and two industry textbooks on electronic patient-reported outcomes (ePRO), and his recent research includes the use of wearables and bring-you-own-device (BYOD) eCOA in clinical trials.  At Signant he provides eCOA science expertise into customer projects and company strategy.

Sayaka Machizawa, Psy.D., is an Associate Director of Clinical Science at Signant Health, bringing over 18 years of expertise in neurodegenerative and psychiatric diseases. She has played a key role in supporting large-scale global clinical trials across a wide range of indications. Fluent in both Japanese and English, Sayaka has led rater training sessions at numerous Investigator Meetings worldwide.

With a Doctorate in Clinical Psychology, she has also dedicated 12 years to academia, teaching graduate-level Psychology courses, and conducting neuropsychological evaluations for diverse populations. Her extensive experience bridges clinical research, education, and applied neuropsychology, making her a valuable contributor to advancing scientific rigor in clinical trials.